Inogen (INGN)
(Delayed Data from NSDQ)
$8.30 USD
+0.19 (2.34%)
Updated May 31, 2024 04:00 PM ET
After-Market: $8.32 +0.02 (0.24%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Brokerage Reports
Inogen, Inc [INGN]
Reports for Purchase
Showing records 121 - 140 ( 284 total )
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Inaugural KBCM Life Sciences & MedTech Forum: Day 1 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Upgrading to OW; Letting Some Air Into a New Investment Thesis
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department